ID   GABR1_HUMAN             Reviewed;         961 AA.
AC   Q9UBS5; B0UXY7; O95375; O95468; O95975; O96022; Q5STL4; Q5SUJ8;
AC   Q5SUL3; Q71SG6; Q86W60; Q9UQQ0;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   11-MAY-2016, entry version 163.
DE   RecName: Full=Gamma-aminobutyric acid type B receptor subunit 1;
DE            Short=GABA-B receptor 1;
DE            Short=GABA-B-R1;
DE            Short=GABA-BR1;
DE            Short=GABABR1;
DE            Short=Gb1;
DE   Flags: Precursor;
GN   Name=GABBR1; Synonyms=GPRC3A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1A AND 1B), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Cerebellum;
RX   PubMed=9844003; DOI=10.1073/pnas.95.25.14991;
RA   Kaupmann K., Schuler V., Mosbacher J., Bischoff S., Bittiger H.,
RA   Heid J., Froestl W., Leonhard S., Pfaff T., Karschin A., Bettler B.;
RT   "Human gamma-aminobutyric acid type B receptors are differentially
RT   expressed and regulate inwardly rectifying K+ channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:14991-14996(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1A; 1B AND 1C), FUNCTION,
RP   SUBUNIT, INTERACTION WITH GABBR2, AND SUBCELLULAR LOCATION.
RC   TISSUE=Cerebellum;
RX   PubMed=9872316; DOI=10.1038/25354;
RA   White J.H., Wise A., Main M.J., Green A., Fraser N.J., Disney G.H.,
RA   Barnes A.A., Emson P., Foord S.M., Marshall F.H.;
RT   "Heterodimerization is required for the formation of a functional
RT   GABA(B) receptor.";
RL   Nature 396:679-682(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1A).
RC   TISSUE=Brain;
RA   Stropp U., Raming K.;
RT   "Human mRNA for GABA-B1a receptor.";
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1A).
RC   TISSUE=Fetal brain;
RX   PubMed=9753614; DOI=10.1006/bbrc.1998.9296;
RA   Grifa A., Totaro A., Rommens J.M., Carella M., Roetto A., Borgato L.,
RA   Zelante L., Gasparini P.;
RT   "GABA (gamma-amino-butyric acid) neurotransmission: identification and
RT   fine mapping of the human GABAB receptor gene.";
RL   Biochem. Biophys. Res. Commun. 250:240-245(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 1A).
RX   PubMed=9798068; DOI=10.1016/S0006-3223(98)00244-3;
RA   Goei V.L., Choi J., Ahn J., Bowlus C.L., Raha-Chowdhury R.,
RA   Gruen J.R.;
RT   "Human gamma-aminobutyric acid B receptor gene: complementary DNA
RT   cloning, expression, chromosomal location, and genomic organization.";
RL   Biol. Psychiatry 44:659-666(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1C).
RC   TISSUE=Cerebellum;
RA   Fraser N.J.;
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1A AND 1B), AND VARIANTS
RP   VAL-20 AND SER-489.
RC   TISSUE=Fetal brain;
RX   PubMed=9933300; DOI=10.1007/s100480050051;
RA   Peters H.C., Kaemmer G., Volz A., Kaupmann K., Ziegler A., Bettler B.,
RA   Epplen J.T., Sander T., Riess O.;
RT   "Mapping, genomic structure, and polymorphisms of the human GABABR1
RT   receptor gene: evaluation of its involvement in idiopathic generalized
RT   epilepsy.";
RL   Neurogenetics 2:47-54(1998).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1A).
RC   TISSUE=Cerebellum;
RX   PubMed=9889352; DOI=10.1016/S0169-328X(98)00316-7;
RA   Makoff A.;
RT   "Molecular cloning of human GABABR1 and its tissue distribution.";
RL   Brain Res. Mol. Brain Res. 64:137-140(1999).
RN   [9]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 1E), AND VARIANT SER-489.
RC   TISSUE=Prostate;
RX   PubMed=10906333; DOI=10.1074/jbc.M005333200;
RA   Schwarz D.A., Barry G., Eliasof S.D., Petroski R.E., Conlon P.J.,
RA   Maki R.A.;
RT   "Characterization of gamma-aminobutyric acid receptor GABAB(1e), a
RT   GABAB(1) splice variant encoding a truncated receptor.";
RL   J. Biol. Chem. 275:32174-32181(2000).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-20.
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1B).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [14]
RP   INTERACTION WITH GABBR2.
RX   PubMed=10773016;
RA   Sullivan R., Chateauneuf A., Coulombe N., Kolakowski L.F. Jr.,
RA   Johnson M.P., Hebert T.E., Ethier N., Belley M., Metters K.,
RA   Abramovitz M., O'Neill G.P., Ng G.Y.K.;
RT   "Coexpression of full-length gamma-aminobutyric acid(B) (GABA(B))
RT   receptors with truncated receptors and metabotropic glutamate receptor
RT   4 supports the GABA(B) heterodimer as the functional receptor.";
RL   J. Pharmacol. Exp. Ther. 293:460-467(2000).
RN   [15]
RP   INTERACTION WITH GABBR2.
RX   PubMed=9872744; DOI=10.1126/science.283.5398.74;
RA   Kuner R., Koehr G., Gruenewald S., Eisenhardt G., Bach A.,
RA   Kornau H.-C.;
RT   "Role of heteromer formation in GABAB receptor function.";
RL   Science 283:74-77(1999).
RN   [16]
RP   INTERACTION WITH JAKMIP1.
RX   PubMed=14718537; DOI=10.1074/jbc.M311737200;
RA   Couve A., Restituito S., Brandon J.M., Charles K.J., Bawagan H.,
RA   Freeman K.B., Pangalos M.N., Calver A.R., Moss S.J.;
RT   "Marlin-1, a novel RNA-binding protein associates with GABA
RT   receptors.";
RL   J. Biol. Chem. 279:13934-13943(2004).
RN   [17]
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=15617512; DOI=10.1042/BJ20041435;
RA   Villemure J.F., Adam L., Bevan N.J., Gearing K., Chenier S.,
RA   Bouvier M.;
RT   "Subcellular distribution of GABA(B) receptor homo- and hetero-
RT   dimers.";
RL   Biochem. J. 388:47-55(2005).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH GABBR2.
RX   PubMed=18165688; DOI=10.1074/jbc.M705202200;
RA   Nomura R., Suzuki Y., Kakizuka A., Jingami H.;
RT   "Direct detection of the interaction between recombinant soluble
RT   extracellular regions in the heterodimeric metabotropic gamma-
RT   aminobutyric acid receptor.";
RL   J. Biol. Chem. 283:4665-4673(2008).
RN   [19]
RP   FUNCTION, PARTIAL PROTEIN SEQUENCE, AGONIST BINDING, MUTAGENESIS OF
RP   TYR-230 AND TYR-234, AND INTERACTION WITH GABBR2.
RX   PubMed=22660477; DOI=10.1038/nn.3133;
RA   Geng Y., Xiong D., Mosyak L., Malito D.L., Kniazeff J., Chen Y.,
RA   Burmakina S., Quick M., Bush M., Javitch J.A., Pin J.P., Fan Q.R.;
RT   "Structure and functional interaction of the extracellular domain of
RT   human GABA(B) receptor GBR2.";
RL   Nat. Neurosci. 15:970-978(2012).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 165-576 IN COMPLEXES WITH
RP   GABBR2; AGONISTS AND ANTAGONISTS, FUNCTION, SUBUNIT, DISULFIDE BOND,
RP   GLYCOSYLATION AT ASN-440 AND ASN-482, AND MUTAGENESIS OF TRP-182;
RP   HIS-287; TYR-367 AND TRP-395.
RX   PubMed=24305054; DOI=10.1038/nature12725;
RA   Geng Y., Bush M., Mosyak L., Wang F., Fan Q.R.;
RT   "Structural mechanism of ligand activation in human GABA(B)
RT   receptor.";
RL   Nature 504:254-259(2013).
RN   [21]
RP   VARIANTS VAL-20 AND SER-489.
RX   PubMed=10402495;
RX   DOI=10.1002/(SICI)1096-8628(19990820)88:4<305::AID-AJMG5>3.0.CO;2-X;
RA   Sander T., Peters C., Kaemmer G., Samochowiec J., Zirra M.,
RA   Mischke D., Ziegler A., Kaupmann K., Bettler B., Epplen J.T.,
RA   Riess O.;
RT   "Association analysis of exonic variants of the gene encoding the
RT   GABAB receptor and idiopathic generalized epilepsy.";
RL   Am. J. Med. Genet. 88:305-310(1999).
CC   -!- FUNCTION: Component of a heterodimeric G-protein coupled receptor
CC       for GABA, formed by GABBR1 and GABBR2. Within the heterodimeric
CC       GABA receptor, only GABBR1 seems to bind agonists, while GABBR2
CC       mediates coupling to G proteins. Ligand binding causes a
CC       conformation change that triggers signaling via guanine
CC       nucleotide-binding proteins (G proteins) and modulates the
CC       activity of down-stream effectors, such as adenylate cyclase.
CC       Signaling inhibits adenylate cyclase, stimulates phospholipase A2,
CC       activates potassium channels, inactivates voltage-dependent
CC       calcium-channels and modulates inositol phospholipid hydrolysis.
CC       Calcium is required for high affinity binding to GABA. Plays a
CC       critical role in the fine-tuning of inhibitory synaptic
CC       transmission. Pre-synaptic GABA receptor inhibits neurotransmitter
CC       release by down-regulating high-voltage activated calcium
CC       channels, whereas postsynaptic GABA receptor decreases neuronal
CC       excitability by activating a prominent inwardly rectifying
CC       potassium (Kir) conductance that underlies the late inhibitory
CC       postsynaptic potentials. Not only implicated in synaptic
CC       inhibition but also in hippocampal long-term potentiation, slow
CC       wave sleep, muscle relaxation and antinociception. Activated by
CC       (-)-baclofen, cgp27492 and blocked by phaclofen.
CC   -!- FUNCTION: Isoform 1E may regulate the formation of functional
CC       GABBR1/GABBR2 heterodimers by competing for GABBR2 binding. This
CC       could explain the observation that certain small molecule ligands
CC       exhibit differential affinity for central versus peripheral sites.
CC   -!- SUBUNIT: Heterodimer of GABBR1 and GABBR2. Homodimers may form,
CC       but are inactive. Isoform 1E (without C-terminal intracellular
CC       domain) is unable to dimerize via a coiled-coil interaction with
CC       GABBR2. Interacts with the leucine zipper of the C-terminal bZIP
CC       domain of ATF4 via its C-terminal region. Interacts with JAKMIP1.
CC       {ECO:0000269|PubMed:10773016, ECO:0000269|PubMed:14718537,
CC       ECO:0000269|PubMed:15617512, ECO:0000269|PubMed:18165688,
CC       ECO:0000269|PubMed:22660477, ECO:0000269|PubMed:24305054,
CC       ECO:0000269|PubMed:9872316, ECO:0000269|PubMed:9872744}.
CC   -!- INTERACTION:
CC       O75899:GABBR2; NbExp=2; IntAct=EBI-724156, EBI-715469;
CC       P61244:MAX; NbExp=3; IntAct=EBI-724156, EBI-751711;
CC       P16333:NCK1; NbExp=3; IntAct=EBI-724156, EBI-389883;
CC       P46459:NSF; NbExp=3; IntAct=EBI-724156, EBI-712251;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cell junction, synapse, postsynaptic cell membrane; Multi-pass
CC       membrane protein. Cell projection, dendrite {ECO:0000250}.
CC       Note=Colocalizes with ATF4 in hippocampal neuron dendritic
CC       membranes (By similarity). Coexpression of GABBR1 and GABBR2 is
CC       required for GABBR1 maturation and transport to the plasma
CC       membrane. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1E: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Isoforms corresponding to the full receptor are
CC         essentially found in the central nervous system (CNS).;
CC       Name=1A;
CC         IsoId=Q9UBS5-1; Sequence=Displayed;
CC       Name=1B;
CC         IsoId=Q9UBS5-2; Sequence=VSP_002037;
CC       Name=1C;
CC         IsoId=Q9UBS5-3; Sequence=VSP_002038;
CC       Name=1D;
CC         IsoId=Q9UBS5-4; Sequence=VSP_002040;
CC       Name=1E; Synonyms=Truncated;
CC         IsoId=Q9UBS5-5; Sequence=VSP_002039;
CC         Note=Major isoform in almost all peripheral tissues, although
CC         containing a premature stop codon in the mRNA and thus being a
CC         potential target for nonsense-mediated mRNA decay. May act as an
CC         antagonist of GABA-B receptors, being able to disrupt the normal
CC         association between isoform 1A and GABBR2.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain and weakly in heart,
CC       small intestine and uterus. Isoform 1A is mostly expressed in
CC       granular cell and molecular layer. Isoform 1B is mostly expressed
CC       in Purkinje cells. Isoform 1E is predominantly expressed in
CC       peripheral tissues as kidney, lung, trachea, colon, small
CC       intestine, stomach, bone marrow, thymus and mammary gland.
CC       {ECO:0000269|PubMed:9844003}.
CC   -!- DOMAIN: Alpha-helical parts of the C-terminal intracellular region
CC       mediate heterodimeric interaction with GABBR2. The linker region
CC       between the transmembrane domain 3 (TM3) and the transmembrane
CC       domain 4 (TM4) probably plays a role in the specificity for G-
CC       protein coupling.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 3 family.
CC       GABA-B receptor subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 2 Sushi (CCP/SCR) domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00302}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ225028; CAA12359.1; -; mRNA.
DR   EMBL; AJ225029; CAA12360.1; -; mRNA.
DR   EMBL; AJ012185; CAA09939.1; -; mRNA.
DR   EMBL; AJ012186; CAA09940.1; -; mRNA.
DR   EMBL; AF099148; AAC98508.1; -; mRNA.
DR   EMBL; Y11044; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AJ012187; CAA09941.1; -; mRNA.
DR   EMBL; AJ010170; CAA09031.1; -; Genomic_DNA.
DR   EMBL; AJ010171; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010172; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010173; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010174; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010175; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010176; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010177; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010178; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010179; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010180; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010181; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010182; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010183; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010184; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010185; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010186; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010187; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010188; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010189; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010190; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010191; CAA09031.1; JOINED; Genomic_DNA.
DR   EMBL; AJ012288; CAA09980.1; -; mRNA.
DR   EMBL; AF301005; AAG23962.1; -; mRNA.
DR   EMBL; AL031983; CAA21453.1; -; Genomic_DNA.
DR   EMBL; AL031983; CAA21454.1; -; Genomic_DNA.
DR   EMBL; AL662826; CAI17390.1; -; Genomic_DNA.
DR   EMBL; AL662826; CAI17391.2; -; Genomic_DNA.
DR   EMBL; AL645936; CAI18016.1; -; Genomic_DNA.
DR   EMBL; AL645936; CAI18017.1; -; Genomic_DNA.
DR   EMBL; BX000688; CAI18605.1; -; Genomic_DNA.
DR   EMBL; BX000688; CAI18606.1; -; Genomic_DNA.
DR   EMBL; CR759766; CAQ06609.1; -; Genomic_DNA.
DR   EMBL; CR759766; CAQ06610.1; -; Genomic_DNA.
DR   EMBL; CR788300; CAQ07763.1; -; Genomic_DNA.
DR   EMBL; CR936483; CAQ07763.1; JOINED; Genomic_DNA.
DR   EMBL; CR788300; CAQ07764.1; -; Genomic_DNA.
DR   EMBL; CR936483; CAQ07764.1; JOINED; Genomic_DNA.
DR   EMBL; CR388210; CAQ09395.1; -; Genomic_DNA.
DR   EMBL; CR759870; CAQ09878.1; -; Genomic_DNA.
DR   EMBL; CR759870; CAQ09879.1; -; Genomic_DNA.
DR   EMBL; CR936483; CAQ10082.1; -; Genomic_DNA.
DR   EMBL; CR788300; CAQ10082.1; JOINED; Genomic_DNA.
DR   EMBL; CR936483; CAQ10083.1; -; Genomic_DNA.
DR   EMBL; CR788300; CAQ10083.1; JOINED; Genomic_DNA.
DR   EMBL; CH471081; EAX03205.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03210.1; -; Genomic_DNA.
DR   EMBL; BC042598; AAH42598.1; -; mRNA.
DR   EMBL; BC050532; AAH50532.2; -; mRNA.
DR   CCDS; CCDS4663.1; -. [Q9UBS5-1]
DR   CCDS; CCDS4664.1; -. [Q9UBS5-3]
DR   CCDS; CCDS4665.1; -. [Q9UBS5-2]
DR   PIR; JE0356; JE0356.
DR   RefSeq; NP_001305982.1; NM_001319053.1.
DR   RefSeq; NP_001461.1; NM_001470.3. [Q9UBS5-1]
DR   RefSeq; NP_068703.1; NM_021903.2. [Q9UBS5-2]
DR   RefSeq; NP_068704.2; NM_021904.3. [Q9UBS5-3]
DR   UniGene; Hs.167017; -.
DR   PDB; 4MQE; X-ray; 2.35 A; A=165-576.
DR   PDB; 4MQF; X-ray; 2.22 A; A=165-576.
DR   PDB; 4MR7; X-ray; 2.15 A; A=165-576.
DR   PDB; 4MR8; X-ray; 2.15 A; A=165-576.
DR   PDB; 4MR9; X-ray; 2.35 A; A=165-576.
DR   PDB; 4MRM; X-ray; 2.86 A; A=165-576.
DR   PDB; 4MS1; X-ray; 2.25 A; A=165-576.
DR   PDB; 4MS3; X-ray; 2.50 A; A=165-576.
DR   PDB; 4MS4; X-ray; 1.90 A; A=165-576.
DR   PDB; 4PAS; X-ray; 1.62 A; A=879-919.
DR   PDBsum; 4MQE; -.
DR   PDBsum; 4MQF; -.
DR   PDBsum; 4MR7; -.
DR   PDBsum; 4MR8; -.
DR   PDBsum; 4MR9; -.
DR   PDBsum; 4MRM; -.
DR   PDBsum; 4MS1; -.
DR   PDBsum; 4MS3; -.
DR   PDBsum; 4MS4; -.
DR   PDBsum; 4PAS; -.
DR   ProteinModelPortal; Q9UBS5; -.
DR   SMR; Q9UBS5; 55-160, 165-576, 884-918.
DR   BioGrid; 108825; 9.
DR   DIP; DIP-38394N; -.
DR   IntAct; Q9UBS5; 11.
DR   MINT; MINT-2793192; -.
DR   STRING; 9606.ENSP00000366233; -.
DR   BindingDB; Q9UBS5; -.
DR   ChEMBL; CHEMBL2111463; -.
DR   DrugBank; DB00181; Baclofen.
DR   DrugBank; DB00837; Progabide.
DR   DrugBank; DB01080; Vigabatrin.
DR   GuidetoPHARMACOLOGY; 240; -.
DR   iPTMnet; Q9UBS5; -.
DR   PhosphoSite; Q9UBS5; -.
DR   BioMuta; GABBR1; -.
DR   DMDM; 12643873; -.
DR   PaxDb; Q9UBS5; -.
DR   PRIDE; Q9UBS5; -.
DR   DNASU; 2550; -.
DR   Ensembl; ENST00000355973; ENSP00000348248; ENSG00000204681. [Q9UBS5-2]
DR   Ensembl; ENST00000376977; ENSP00000366176; ENSG00000204681. [Q9UBS5-5]
DR   Ensembl; ENST00000377012; ENSP00000366211; ENSG00000204681. [Q9UBS5-2]
DR   Ensembl; ENST00000377016; ENSP00000366215; ENSG00000204681. [Q9UBS5-3]
DR   Ensembl; ENST00000377034; ENSP00000366233; ENSG00000204681. [Q9UBS5-1]
DR   Ensembl; ENST00000383537; ENSP00000373029; ENSG00000206466. [Q9UBS5-2]
DR   Ensembl; ENST00000383541; ENSP00000373033; ENSG00000206466. [Q9UBS5-3]
DR   Ensembl; ENST00000383542; ENSP00000373034; ENSG00000206466. [Q9UBS5-1]
DR   Ensembl; ENST00000383543; ENSP00000373035; ENSG00000206466. [Q9UBS5-2]
DR   Ensembl; ENST00000383636; ENSP00000373132; ENSG00000206511. [Q9UBS5-2]
DR   Ensembl; ENST00000383637; ENSP00000373133; ENSG00000206511. [Q9UBS5-3]
DR   Ensembl; ENST00000383638; ENSP00000373134; ENSG00000206511. [Q9UBS5-1]
DR   Ensembl; ENST00000383639; ENSP00000373135; ENSG00000206511. [Q9UBS5-2]
DR   Ensembl; ENST00000414980; ENSP00000406499; ENSG00000232632. [Q9UBS5-2]
DR   Ensembl; ENST00000417759; ENSP00000391572; ENSG00000237112. [Q9UBS5-2]
DR   Ensembl; ENST00000419674; ENSP00000399861; ENSG00000232569. [Q9UBS5-3]
DR   Ensembl; ENST00000423604; ENSP00000388035; ENSG00000232632. [Q9UBS5-1]
DR   Ensembl; ENST00000425097; ENSP00000411286; ENSG00000237112. [Q9UBS5-1]
DR   Ensembl; ENST00000434660; ENSP00000412167; ENSG00000232632. [Q9UBS5-3]
DR   Ensembl; ENST00000438094; ENSP00000406285; ENSG00000232632. [Q9UBS5-2]
DR   Ensembl; ENST00000439457; ENSP00000406066; ENSG00000232569. [Q9UBS5-1]
DR   Ensembl; ENST00000443440; ENSP00000399318; ENSG00000237112. [Q9UBS5-3]
DR   Ensembl; ENST00000446436; ENSP00000394528; ENSG00000237112. [Q9UBS5-2]
DR   Ensembl; ENST00000448754; ENSP00000405709; ENSG00000237051. [Q9UBS5-2]
DR   Ensembl; ENST00000449163; ENSP00000411263; ENSG00000232569. [Q9UBS5-2]
DR   Ensembl; ENST00000452300; ENSP00000408938; ENSG00000232569. [Q9UBS5-2]
DR   Ensembl; ENST00000458612; ENSP00000416903; ENSG00000237051. [Q9UBS5-2]
DR   Ensembl; ENST00000494877; ENSP00000419061; ENSG00000204681. [Q9UBS5-5]
DR   Ensembl; ENST00000546913; ENSP00000448999; ENSG00000232569. [Q9UBS5-1]
DR   Ensembl; ENST00000547410; ENSP00000448531; ENSG00000232569. [Q9UBS5-5]
DR   Ensembl; ENST00000548767; ENSP00000446983; ENSG00000232632. [Q9UBS5-5]
DR   Ensembl; ENST00000551140; ENSP00000448654; ENSG00000237112. [Q9UBS5-5]
DR   Ensembl; ENST00000551423; ENSP00000449342; ENSG00000206511. [Q9UBS5-5]
DR   Ensembl; ENST00000552399; ENSP00000449449; ENSG00000206466. [Q9UBS5-5]
DR   GeneID; 2550; -.
DR   KEGG; hsa:2550; -.
DR   UCSC; uc003nmp.5; human. [Q9UBS5-1]
DR   CTD; 2550; -.
DR   GeneCards; GABBR1; -.
DR   HGNC; HGNC:4070; GABBR1.
DR   HPA; HPA050483; -.
DR   MIM; 603540; gene.
DR   neXtProt; NX_Q9UBS5; -.
DR   PharmGKB; PA28484; -.
DR   eggNOG; KOG1055; Eukaryota.
DR   eggNOG; ENOG410XNN1; LUCA.
DR   GeneTree; ENSGT00530000063129; -.
DR   HOGENOM; HOG000171607; -.
DR   HOVERGEN; HBG051688; -.
DR   InParanoid; Q9UBS5; -.
DR   KO; K04615; -.
DR   OMA; PKICQAR; -.
DR   PhylomeDB; Q9UBS5; -.
DR   TreeFam; TF313965; -.
DR   Reactome; R-HSA-1296041; Activation of G protein gated Potassium channels.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   Reactome; R-HSA-420499; Class C/3 (Metabotropic glutamate/pheromone receptors).
DR   Reactome; R-HSA-977444; GABA B receptor activation.
DR   Reactome; R-HSA-997272; Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits.
DR   ChiTaRS; GABBR1; human.
DR   GeneWiki; GABBR1; -.
DR   GenomeRNAi; 2550; -.
DR   NextBio; 10061; -.
DR   PRO; PR:Q9UBS5; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; Q9UBS5; -.
DR   CleanEx; HS_GABBR1; -.
DR   ExpressionAtlas; Q9UBS5; baseline and differential.
DR   Genevisible; Q9UBS5; HS.
DR   GO; GO:0030673; C:axolemma; IEA:Ensembl.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0043198; C:dendritic shaft; IEA:Ensembl.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:Ensembl.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0038039; C:G-protein coupled receptor heterodimeric complex; IPI:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:Ensembl.
DR   GO; GO:0008021; C:synaptic vesicle; IEA:Ensembl.
DR   GO; GO:0004965; F:G-protein coupled GABA receptor activity; IDA:UniProtKB.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0033602; P:negative regulation of dopamine secretion; IEA:Ensembl.
DR   GO; GO:0032811; P:negative regulation of epinephrine secretion; IEA:Ensembl.
DR   GO; GO:0014053; P:negative regulation of gamma-aminobutyric acid secretion; IEA:Ensembl.
DR   GO; GO:0050805; P:negative regulation of synaptic transmission; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0014049; P:positive regulation of glutamate secretion; IEA:Ensembl.
DR   GO; GO:0060124; P:positive regulation of growth hormone secretion; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0035094; P:response to nicotine; IEA:Ensembl.
DR   GO; GO:0007268; P:synaptic transmission; TAS:Reactome.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR002455; GPCR3_GABA-B.
DR   InterPro; IPR017978; GPCR_3_C.
DR   InterPro; IPR002456; GPCR_3_GABA_rcpt_B1.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR000436; Sushi_SCR_CCP_dom.
DR   PANTHER; PTHR10519; PTHR10519; 1.
DR   PANTHER; PTHR10519:SF42; PTHR10519:SF42; 1.
DR   Pfam; PF00003; 7tm_3; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00084; Sushi; 1.
DR   PRINTS; PR01177; GABAB1RECPTR.
DR   SMART; SM00032; CCP; 2.
DR   SUPFAM; SSF53822; SSF53822; 1.
DR   SUPFAM; SSF57535; SSF57535; 2.
DR   PROSITE; PS50259; G_PROTEIN_RECEP_F3_4; 1.
DR   PROSITE; PS50923; SUSHI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Cell projection; Coiled coil; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Membrane; Phosphoprotein; Polymorphism;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Repeat;
KW   Secreted; Signal; Sushi; Synapse; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     14       {ECO:0000255}.
FT   CHAIN        15    961       Gamma-aminobutyric acid type B receptor
FT                                subunit 1.
FT                                /FTId=PRO_0000012949.
FT   TOPO_DOM     15    591       Extracellular. {ECO:0000255}.
FT   TRANSMEM    592    612       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM    613    631       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    632    652       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    653    667       Extracellular. {ECO:0000255}.
FT   TRANSMEM    668    688       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    689    710       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    711    731       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    732    768       Extracellular. {ECO:0000255}.
FT   TRANSMEM    769    789       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    790    804       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    805    825       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    826    833       Extracellular. {ECO:0000255}.
FT   TRANSMEM    834    854       Helical; Name=7. {ECO:0000255}.
FT   TOPO_DOM    855    961       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       30     96       Sushi 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN       98    159       Sushi 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   REGION      888    916       Interaction with ATF4. {ECO:0000250}.
FT   COILED      869    925       {ECO:0000255}.
FT   BINDING     247    247       Agonist.
FT   BINDING     270    270       Agonist.
FT   BINDING     287    287       Agonist.
FT   BINDING     367    367       Agonist.
FT   BINDING     395    395       Agonist.
FT   BINDING     466    466       Agonist.
FT   MOD_RES     873    873       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9WV18}.
FT   MOD_RES     930    930       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9WV18}.
FT   CARBOHYD     24     24       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD     84     84       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    409    409       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    440    440       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:24305054}.
FT   CARBOHYD    482    482       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:24305054}.
FT   CARBOHYD    502    502       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    514    514       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID    100    145       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    131    157       {ECO:0000255|PROSITE-ProRule:PRU00302}.
FT   DISULFID    220    246       {ECO:0000255|PROSITE-ProRule:PRU00302,
FT                                ECO:0000269|PubMed:24305054}.
FT   DISULFID    376    410       {ECO:0000255|PROSITE-ProRule:PRU00302,
FT                                ECO:0000269|PubMed:24305054}.
FT   VAR_SEQ       1    164       MLLLLLLAPLFLRPPGAGGAQTPNATSEGCQIIHPPWEGGI
FT                                RYRGLTRDQVKAINFLPVDYEIEYVCRGEREVVGPKVRKCL
FT                                ANGSWTDMDTPSRCVRICSKSYLTLENGKVFLTGGDLPALD
FT                                GARVDFRCDPDFHLVGSSRSICSQGQWSTPKPHCQVNRTPH
FT                                -> MGPGAPFARVGWPLPLLVVMAAGVAPVWASHSPHLPRP
FT                                HSRVPPHPS (in isoform 1B).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9844003,
FT                                ECO:0000303|PubMed:9872316}.
FT                                /FTId=VSP_002037.
FT   VAR_SEQ      98    159       Missing (in isoform 1C).
FT                                {ECO:0000303|PubMed:9872316,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_002038.
FT   VAR_SEQ     570    961       GGSPPADQTLVIKTFRFLSQKLFISVSVLSSLGIVLAVVCL
FT                                SFNIYNSHVRYIQNSQPNLNNLTAVGCSLALAAVFPLGLDG
FT                                YHIGRNQFPFVCQARLWLLGLGFSLGYGSMFTKIWWVHTVF
FT                                TKKEEKKEWRKTLEPWKLYATVGLLVGMDVLTLAIWQIVDP
FT                                LHRTIETFAKEEPKEDIDVSILPQLEHCSSRKMNTWLGIFY
FT                                GYKGLLLLLGIFLAYETKSVSTEKINDHRAVGMAIYNVAVL
FT                                CLITAPVTMILSSQQDAAFAFASLAIVFSSYITLVVLFVPK
FT                                MRRLITRGEWQSEAQDTMKTGSSTNNNEEEKSRLLEKENRE
FT                                LEKIIAEKEERVSELRHQLQSRQQLRSRRHPPTPPEPSGGL
FT                                PRGPPEPPDRLSCDGSRVHLLYK -> VISRTHSPT (in
FT                                isoform 1E). {ECO:0000305}.
FT                                /FTId=VSP_002039.
FT   VAR_SEQ     905    961       KEERVSELRHQLQSRQQLRSRRHPPTPPEPSGGLPRGPPEP
FT                                PDRLSCDGSRVHLLYK -> SGGLPRGPPEPPDRLSCDGSR
FT                                VHLLYK (in isoform 1D). {ECO:0000305}.
FT                                /FTId=VSP_002040.
FT   VARIANT      20     20       A -> V (in dbSNP:rs1805056).
FT                                {ECO:0000269|PubMed:10402495,
FT                                ECO:0000269|PubMed:14574404,
FT                                ECO:0000269|PubMed:9933300}.
FT                                /FTId=VAR_010146.
FT   VARIANT     489    489       G -> S (in dbSNP:rs1805057).
FT                                {ECO:0000269|PubMed:10402495,
FT                                ECO:0000269|PubMed:10906333,
FT                                ECO:0000269|PubMed:9933300}.
FT                                /FTId=VAR_010147.
FT   VARIANT     645    645       F -> L (in dbSNP:rs2076489).
FT                                /FTId=VAR_049279.
FT   MUTAGEN     182    182       W->A: Abolishes signaling via G-proteins.
FT                                Abolishes antagonist binding.
FT                                {ECO:0000269|PubMed:24305054}.
FT   MUTAGEN     230    230       Y->A: Slightly decreases signaling via G-
FT                                proteins. {ECO:0000269|PubMed:22660477}.
FT   MUTAGEN     234    234       Y->A: Decreases signaling via G-proteins.
FT                                {ECO:0000269|PubMed:22660477}.
FT   MUTAGEN     287    287       H->A: Strongly reduces signaling via G-
FT                                proteins. Abolishes antagonist binding.
FT                                {ECO:0000269|PubMed:24305054}.
FT   MUTAGEN     367    367       Y->A: Strongly reduces signaling via G-
FT                                proteins. No effect on antagonist
FT                                binding. {ECO:0000269|PubMed:24305054}.
FT   MUTAGEN     395    395       W->A: Strongly reduces signaling via G-
FT                                proteins. Strongly reduces antagonist
FT                                binding. {ECO:0000269|PubMed:24305054}.
FT   CONFLICT      2      2       L -> M (in Ref. 4; Y11044).
FT                                {ECO:0000305}.
FT   CONFLICT     21     21       Q -> H (in Ref. 2; CAA09939/CAA09941).
FT                                {ECO:0000305}.
FT   CONFLICT     93     93       P -> L (in Ref. 3; AAC98508).
FT                                {ECO:0000305}.
FT   CONFLICT    127    127       V -> A (in Ref. 2; CAA09939).
FT                                {ECO:0000305}.
FT   CONFLICT    322    322       Missing (in Ref. 7; CAA09031).
FT                                {ECO:0000305}.
FT   CONFLICT    542    542       L -> P (in Ref. 4; Y11044).
FT                                {ECO:0000305}.
FT   CONFLICT    691    691       V -> G (in Ref. 4; Y11044).
FT                                {ECO:0000305}.
FT   CONFLICT    905    934       Missing (in Ref. 7; CAA09031).
FT                                {ECO:0000305}.
FT   STRAND      168    176       {ECO:0000244|PDB:4MS4}.
FT   STRAND      178    181       {ECO:0000244|PDB:4MS4}.
FT   HELIX       185    200       {ECO:0000244|PDB:4MS4}.
FT   TURN        203    205       {ECO:0000244|PDB:4MS4}.
FT   STRAND      209    217       {ECO:0000244|PDB:4MS4}.
FT   HELIX       222    233       {ECO:0000244|PDB:4MS4}.
FT   STRAND      234    237       {ECO:0000244|PDB:4MS4}.
FT   STRAND      240    243       {ECO:0000244|PDB:4MS4}.
FT   HELIX       247    256       {ECO:0000244|PDB:4MS4}.
FT   HELIX       257    260       {ECO:0000244|PDB:4MS4}.
FT   STRAND      263    268       {ECO:0000244|PDB:4MS4}.
FT   HELIX       272    275       {ECO:0000244|PDB:4MS4}.
FT   TURN        277    279       {ECO:0000244|PDB:4MS4}.
FT   STRAND      283    287       {ECO:0000244|PDB:4MS4}.
FT   HELIX       290    292       {ECO:0000244|PDB:4MS4}.
FT   HELIX       293    303       {ECO:0000244|PDB:4MS4}.
FT   STRAND      308    316       {ECO:0000244|PDB:4MS4}.
FT   HELIX       317    332       {ECO:0000244|PDB:4MS4}.
FT   STRAND      336    345       {ECO:0000244|PDB:4MS4}.
FT   HELIX       348    356       {ECO:0000244|PDB:4MS4}.
FT   STRAND      361    365       {ECO:0000244|PDB:4MS4}.
FT   HELIX       368    381       {ECO:0000244|PDB:4MS4}.
FT   STRAND      385    387       {ECO:0000244|PDB:4MRM}.
FT   STRAND      389    393       {ECO:0000244|PDB:4MS4}.
FT   HELIX       400    402       {ECO:0000244|PDB:4MS4}.
FT   HELIX       412    419       {ECO:0000244|PDB:4MS4}.
FT   STRAND      423    427       {ECO:0000244|PDB:4MS4}.
FT   HELIX       443    453       {ECO:0000244|PDB:4MS4}.
FT   HELIX       458    460       {ECO:0000244|PDB:4MS4}.
FT   TURN        462    466       {ECO:0000244|PDB:4MS4}.
FT   HELIX       467    484       {ECO:0000244|PDB:4MS4}.
FT   HELIX       495    497       {ECO:0000244|PDB:4MS4}.
FT   HELIX       504    514       {ECO:0000244|PDB:4MS4}.
FT   STRAND      517    520       {ECO:0000244|PDB:4MS4}.
FT   STRAND      523    526       {ECO:0000244|PDB:4MS4}.
FT   TURN        529    531       {ECO:0000244|PDB:4MS4}.
FT   STRAND      536    543       {ECO:0000244|PDB:4MS4}.
FT   STRAND      546    554       {ECO:0000244|PDB:4MS4}.
FT   TURN        555    558       {ECO:0000244|PDB:4MS4}.
FT   STRAND      559    562       {ECO:0000244|PDB:4MS4}.
FT   HELIX       569    571       {ECO:0000244|PDB:4MS4}.
FT   HELIX       885    917       {ECO:0000244|PDB:4PAS}.
SQ   SEQUENCE   961 AA;  108320 MW;  54E7349CD02B633F CRC64;
     MLLLLLLAPL FLRPPGAGGA QTPNATSEGC QIIHPPWEGG IRYRGLTRDQ VKAINFLPVD
     YEIEYVCRGE REVVGPKVRK CLANGSWTDM DTPSRCVRIC SKSYLTLENG KVFLTGGDLP
     ALDGARVDFR CDPDFHLVGS SRSICSQGQW STPKPHCQVN RTPHSERRAV YIGALFPMSG
     GWPGGQACQP AVEMALEDVN SRRDILPDYE LKLIHHDSKC DPGQATKYLY ELLYNDPIKI
     ILMPGCSSVS TLVAEAARMW NLIVLSYGSS SPALSNRQRF PTFFRTHPSA TLHNPTRVKL
     FEKWGWKKIA TIQQTTEVFT STLDDLEERV KEAGIEITFR QSFFSDPAVP VKNLKRQDAR
     IIVGLFYETE ARKVFCEVYK ERLFGKKYVW FLIGWYADNW FKIYDPSINC TVDEMTEAVE
     GHITTEIVML NPANTRSISN MTSQEFVEKL TKRLKRHPEE TGGFQEAPLA YDAIWALALA
     LNKTSGGGGR SGVRLEDFNY NNQTITDQIY RAMNSSSFEG VSGHVVFDAS GSRMAWTLIE
     QLQGGSYKKI GYYDSTKDDL SWSKTDKWIG GSPPADQTLV IKTFRFLSQK LFISVSVLSS
     LGIVLAVVCL SFNIYNSHVR YIQNSQPNLN NLTAVGCSLA LAAVFPLGLD GYHIGRNQFP
     FVCQARLWLL GLGFSLGYGS MFTKIWWVHT VFTKKEEKKE WRKTLEPWKL YATVGLLVGM
     DVLTLAIWQI VDPLHRTIET FAKEEPKEDI DVSILPQLEH CSSRKMNTWL GIFYGYKGLL
     LLLGIFLAYE TKSVSTEKIN DHRAVGMAIY NVAVLCLITA PVTMILSSQQ DAAFAFASLA
     IVFSSYITLV VLFVPKMRRL ITRGEWQSEA QDTMKTGSST NNNEEEKSRL LEKENRELEK
     IIAEKEERVS ELRHQLQSRQ QLRSRRHPPT PPEPSGGLPR GPPEPPDRLS CDGSRVHLLY
     K
//
